Clene Inc. Shareholders' Equity
Clene Inc. (CLNN) had Shareholders' Equity of -$24.78 million as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-08-14
- 2026-06-30: Stockholders' Equity Attributable to Parent -$24.78M.
- 2026-03-31: Stockholders' Equity Attributable to Parent -$18.81M.
- 2025-12-31: Stockholders' Equity Attributable to Parent -$17.59M.
- 2025-09-30: Stockholders' Equity Attributable to Parent -$12.36M.
| Period end | Stockholders' Equity Attributable to Parent | Stockholders' Equity Attributable to Parent as first filed |
|---|---|---|
| 2026-06-30 | -$24.78M 10-Q · filed 2026-08-14 | |
| 2026-03-31 | -$18.81M 10-Q · filed 2026-08-14 | |
| 2025-12-31 | -$17.59M 10-Q · filed 2026-08-14 | |
| 2025-09-30 | -$12.36M 10-Q · filed 2025-11-13 | |
| 2025-06-30 | -$8.55M 10-Q · filed 2026-08-14 | |
| 2025-03-31 | -$4.97M 10-Q · filed 2026-08-14 | |
| 2024-12-31 | -$8.86M 10-Q · filed 2026-08-14 | |
| 2024-09-30 | -$4.13M 10-Q · filed 2025-11-13 | |
| 2024-06-30 | -$504.00K 10-Q · filed 2025-11-13 | |
| 2024-03-31 | $4.26M 10-Q · filed 2025-11-13 | |
| 2023-12-31 | $13.39M 10-K · filed 2026-03-17 | |
| 2023-09-30 | $21.40M 10-Q · filed 2024-11-13 | $21.41M 10-Q · filed 2023-11-07 |
| 2023-06-30 | $21.53M 10-Q · filed 2024-11-13 | $21.53M 10-Q · filed 2023-08-14 |
| 2023-03-31 | -$1.63M 10-Q · filed 2024-11-13 | -$1.63M 10-Q · filed 2023-05-12 |
| 2022-12-31 | $3.24M 10-K · filed 2025-03-24 | |
| 2022-09-30 | -$9.32M 10-Q · filed 2023-11-07 | |
| 2022-06-30 | -$563.00K 10-Q · filed 2023-11-07 | |
| 2022-03-31 | $2.02M 10-Q · filed 2023-11-07 | |
| 2021-12-31 | $12.60M 10-K · filed 2024-03-13 | |
| 2021-09-30 | $5.69M 10-Q · filed 2022-11-07 | |
| 2021-06-30 | -$25.93M 10-Q · filed 2022-11-07 | |
| 2021-03-31 | -$36.08M 10-Q · filed 2022-11-07 | |
| 2020-12-31 | $341.00K 10-K · filed 2023-03-13 | |
| 2020-09-30 | -$87.25M 10-Q · filed 2021-11-08 | |
| 2020-06-30 | -$77.17M 10-Q · filed 2021-11-08 | |
| 2020-03-31 | -$71.54M 10-Q · filed 2021-11-08 | |
| 2019-12-31 | -$67.77M 10-K · filed 2022-03-11 | |
| 2018-12-31 | -$52.04M 10-K · filed 2021-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Serina Therapeutics, Inc. (SER) | United States | $0.054B | -2.35 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B | |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| TALPHERA, INC. (TLPH) | United States | $0.060B |